Condition
FGFR Gene Amplification clinical trials and research
As of November 12, 2026, Find a Trial lists 2 FGFR Gene Amplification clinical trials that are recruiting, at sites in 7 countries (most in United States (2), Australia (1), Italy (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
TYRA-300 for FGFR3‑altered low‑grade, intermediate‑risk non‑muscle invasive bladder cancer
This trial tests whether the oral drug TYRA-300 can help people with low‑grade, intermediate‑risk non‑muscle invasive bladder cancer that has FGFR3 changes.
-
Evaluating TYRA-430 for advanced liver and solid tumors with specific genetic changes
This study is testing a new drug called TYRA-430 to see if it can help people with advanced liver and other solid tumors that have certain genetic changes.
Related topics
Quick answers
How many FGFR Gene Amplification clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (2 trials), Australia (1 trial), Italy (1 trial), Spain (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.